Previous 10 | Next 10 |
2024-03-27 14:43:59 ET Shares of iBio Inc (NYSEAMERICAN: IBIO) close to tripled on Wednesday after the biotechnology company announced a collaboration with AstralBio Inc. iBio stock is still down sharply versus a year ago The $12 million company based out of Texas, United States...
2024-03-27 13:57:15 ET DENVER, Colo., Mar 27, 2024 ( 247marketnews.com )- This morning’s notable listings with recent news include Treasure & Shipwreck Recovery (OTCPK: BLIS ), iBio, Inc. (NYSEAMERICAN: IBIO ), Trump Media & Technology Group (NASDAQ:...
2024-03-27 12:00:47 ET More on iBio iBio announces $15 million private placement iBio stock jumps on sale of preclinical PD-1 agonist antibody program Financial information for iBio Read the full article on Seeking Alpha For further details see: i...
2024-03-27 10:00:45 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run John...
A look at the top 10 most actives in the United States Verb Technology Company Inc. (VERB) rose 34.1% to $0.3754 on volume of 55,110,141 shares Gamida Cell Ltd. (GMDA) fell 82.7% to $0.0594 on volume of 50,587,982 shares iBio Inc. (IBIO) rose 111.3% to $2.43 on volume of 40,863,066 shares...
– Leading AI and precision biologics innovators to build a diverse set of novel best-in-class obesity treatments – – iBio to use its patented generative AI/Machine Learning platform to discover, engineer and develop obesity-focused therapeutic targets – ...
2024-03-27 03:13:31 ET More on iBio iBio stock jumps on sale of preclinical PD-1 agonist antibody program Financial information for iBio Read the full article on Seeking Alpha For further details see: iBio announces $15 million private placement
– Purchase price of $2.85 represents a premium of 148+% to last close – BRYAN, Texas and SAN DIEGO, March 26, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision antibody immunotherapies,...
– Deal includes $1 million upfront and potential future milestone payments – – iBio’s proprietary therapeutic pipeline will now be comprised entirely of promising immuno-oncology candidates – BRYAN, Texas and SAN DIEGO, Feb. 26, 2024 (GLOBE NEWSW...
BRYAN, Texas and SAN DIEGO, Jan. 16, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision antibody immunotherapies, announced today that Matthew P. Greving Ph.D ., its Vice President and Head of Platform Te...
News, Short Squeeze, Breakout and More Instantly...
2024-03-28 13:35:17 ET DENVER, Colo., Mar 28, 2024 ( 247marketnews.com )- This morning’s notable listings with recent news include Trump Media & Technology Group (NASDAQ:DJT), iBio, Inc. (NYSEAMERICAN: IBIO ), Siyata Mobile (NASDAQ: SYTA ), CERo Therapeu...
A look at the top 10 most actives in the United States Akanda Corp. (AKAN) rose 54.8% to $0.2552 on volume of 35,107,796 shares Nikola Corporation (NKLA) rose 5.0% to $0.9546 on volume of 25,515,019 shares Biodexa Pharmaceuticals plc (BDRX) rose 83.9% to $1.58 on volume of 24,185,655 shar...